期刊文献+

Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma 被引量:2

Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma
下载PDF
导出
摘要 In the Algorithm for Diagnosis and Treatment in the Japanese Evidence-Based Clinical Practice Guidelines for Hepatocellular Carcinoma, the treatment strategy is determined by three major factors: liver function and the number and size of tumors. The algorithm is quite simple, consisting of fewer components than the Barcelona-Clinic Liver Cancer staging system. In this article, we describe the roles of the treatment algorithmin hepatectomy and perioperative management of hepatocellular carcinoma. In the Algorithm for Diagnosis and Treatment in theJapanese Evidence-Based Clinical Practice Guidelinesfor Hepatocellular Carcinoma, the treatment strategyis determined by three major factors liver functionand the number and size of tumors. The algorithm isquite simple, consisting of fewer components than theBarcelona-Clinic Liver Cancer staging system. In thisarticle, we describe the roles of the treatment algorithmin hepatectomy and perioperative management ofhepatocellular carcinoma.
出处 《World Journal of Hepatology》 CAS 2015年第2期261-269,共9页 世界肝病学杂志(英文版)(电子版)
基金 Supported by A Grant-in-Aid for Scientific Research(C)25350856 from the Ministry of Education,Culture,Sports,Science and Technology(MEXT),Japan
关键词 HEPATOCELLULAR CARCINOMA GUIDELINE Liverresection Treatment algorithm Hepatocellular carcinoma Guideline Liver resection Treatment algorithm
  • 相关文献

参考文献87

  • 1Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma.Lancet 2012; 379: 1245-1255 [PMID: 22353262 DOI: 10.1016/s0140-6736(11)61347-0].
  • 2Bruix J, Sherman M. Management of hepatocellular carcinoma: anupdate. Hepatology 2011; 53: 1020-1022 [PMID: 21374666 DOI:10.1002/hep.24199].
  • 3Kokudo N, Makuuchi M. Evidence-based clinical practiceguidelines for hepatocellular carcinoma in Japan: the J-HCCguidelines. J Gastroenterol 2009; 44 Suppl 19: 119-121 [PMID:19148805 DOI: 10.1007/s00535-008-2244-z].
  • 4Makuuchi M, Kokudo N, Arii S, Futagawa S, Kaneko S,Kawasaki S, Matsuyama Y, Okazaki M, Okita K, Omata M, SaidaY, Takayama T, Yamaoka Y. Development of evidence-basedclinical guidelines for the diagnosis and treatment of hepatocellularcarcinoma in Japan. Hepatol Res 2008; 38: 37-51 [PMID: 18039202DOI: 10.1111/j.1872-034X.2007.00216.x].
  • 5Hepatology JSo. Clinical practice guidelines for hepatocellularcarcinoma. Tokyo, Japan: Kanehara, 2013.
  • 6Kokudo N, Sasaki Y, Nakayama T, Makuuchi M. Disseminationof evidence-based clinical practice guidelines for hepatocellularcarcinoma among Japanese hepatologists, liver surgeons andprimary care physicians. Gut 2007; 56: 1020-1021 [PMID:17566034 DOI: 10.1136/gut.2007.119362].
  • 7Sobin LH, Compton CC. TNM seventh edition: what's new, what'schanged: communication from the International Union Against Cancerand the American Joint Committee on Cancer. Cancer 2010; 116:5336-5339 [PMID: 20665503 DOI: 10.1002/cncr.25537].
  • 8Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, MirzaN, Curley SA, Ellis LM, Regimbeau JM, Rashid A, Cleary KR,Nagorney DM. Simplified staging for hepatocellular carcinoma. JClin Oncol 2002; 20: 1527-1536 [PMID: 11896101].
  • 9Japan LCSGo. General rules for the clinical and pathological studyof primary liver cancer. 3rd ed. Tokyo: Kanehara, 2010.
  • 10Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M.Staging of hepatocellular carcinoma: assessment of the JapaneseTNM and AJCC/UICC TNM systems in a cohort of 13,772 patientsin Japan. Ann Surg 2007; 245: 909-922 [PMID: 17522517 DOI:10.1097/01.sla.0000254368.65878.da].

同被引文献22

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部